137 related articles for article (PubMed ID: 37870061)
21. CRISPR-Based Technologies: Impact of RNA-Targeting Systems.
Terns MP
Mol Cell; 2018 Nov; 72(3):404-412. PubMed ID: 30388409
[TBL] [Abstract][Full Text] [Related]
22. Systematic optimization of square-wave electroporation conditions for bovine primary fibroblasts.
Hyder I; Eghbalsaied S; Kues WA
BMC Mol Cell Biol; 2020 Feb; 21(1):9. PubMed ID: 32111153
[TBL] [Abstract][Full Text] [Related]
23. An Electrochemical Protocol for CRISPR-Mediated Gene-Editing of Sheep Embryonic Fibroblast Cells.
Eghbalsaied S; Kues WA
Cells Tissues Organs; 2023; 212(2):176-184. PubMed ID: 34823242
[TBL] [Abstract][Full Text] [Related]
24. CRISPR/Cas9-mediated 2-sgRNA cleavage facilitates pseudorabies virus editing.
Tang YD; Guo JC; Wang TY; Zhao K; Liu JT; Gao JC; Tian ZJ; An TQ; Cai XH
FASEB J; 2018 Aug; 32(8):4293-4301. PubMed ID: 29509513
[TBL] [Abstract][Full Text] [Related]
25. Efficient homology-directed gene editing by CRISPR/Cas9 in human stem and primary cells using tube electroporation.
Xu X; Gao D; Wang P; Chen J; Ruan J; Xu J; Xia X
Sci Rep; 2018 Aug; 8(1):11649. PubMed ID: 30076383
[TBL] [Abstract][Full Text] [Related]
26. Electroporation of AsCpf1/RNP at the Zygote Stage is an Efficient Genome Editing Method to Generate Knock-Out Mice Deficient in Leukemia Inhibitory Factor.
Kim YS; Kim GR; Park M; Yang SC; Park SH; Won JE; Lee JH; Shin HE; Song H; Kim HR
Tissue Eng Regen Med; 2020 Feb; 17(1):45-53. PubMed ID: 32002841
[TBL] [Abstract][Full Text] [Related]
27. CRISPR-Cas9 for cancer therapy: Opportunities and challenges.
Chen M; Mao A; Xu M; Weng Q; Mao J; Ji J
Cancer Lett; 2019 Apr; 447():48-55. PubMed ID: 30684591
[TBL] [Abstract][Full Text] [Related]
28. Genome Editing in Mouse and Rat by Electroporation.
Kaneko T
Methods Mol Biol; 2023; 2637():125-134. PubMed ID: 36773143
[TBL] [Abstract][Full Text] [Related]
29. Rapid and efficient generation of antigen-specific isogenic T cells from cryopreserved blood samples.
Eerkens AL; Vledder A; van Rooij N; Foijer F; Nijman HW; de Bruyn M
Immunol Cell Biol; 2022 Apr; 100(4):285-295. PubMed ID: 35194830
[TBL] [Abstract][Full Text] [Related]
30. The versatile electric condition in mouse embryos for genome editing using a three-step square-wave pulse electroporator.
Nakano K; Shimizu Y; Arai T; Kaneko T; Okamura T
Exp Anim; 2022 May; 71(2):214-223. PubMed ID: 34880157
[TBL] [Abstract][Full Text] [Related]
31. Improved Delivery of CRISPR/Cas9 System Using Magnetic Nanoparticles into Porcine Fibroblast.
Hryhorowicz M; Grześkowiak B; Mazurkiewicz N; Śledziński P; Lipiński D; Słomski R
Mol Biotechnol; 2019 Mar; 61(3):173-180. PubMed ID: 30560399
[TBL] [Abstract][Full Text] [Related]
32. Establishment of protocol for preparation of gene-edited bovine ear-derived fibroblasts for somatic cell nuclear transplantation.
Ishino T; Hashimoto M; Amagasa M; Saito N; Dochi O; Kirisawa R; Kitamura H
Biomed Res; 2018; 39(2):95-104. PubMed ID: 29669988
[TBL] [Abstract][Full Text] [Related]
33. Production of genome-edited mice by visualization of nucleases introduced into the embryos using electroporation.
Wake Y; Kaneko T
J Reprod Dev; 2020 Oct; 66(5):469-473. PubMed ID: 32713893
[TBL] [Abstract][Full Text] [Related]
34. CRISPR/Cas9-mediated knockout of clinically relevant alloantigenes in human primary T cells.
Kamali E; Rahbarizadeh F; Hojati Z; Frödin M
BMC Biotechnol; 2021 Jan; 21(1):9. PubMed ID: 33514392
[TBL] [Abstract][Full Text] [Related]
35. Targeted Genome Editing Using DNA-Free RNA-Guided Cas9 Ribonucleoprotein for CHO Cell Engineering.
Shin J; Lee N; Cho S; Cho BK
Methods Mol Biol; 2018; 1772():151-169. PubMed ID: 29754227
[TBL] [Abstract][Full Text] [Related]
36. Multiple Applications of a Transient CRISPR-Cas9 Coupled with Electroporation (TRACE) System in the
Fan Y; Lin X
Genetics; 2018 Apr; 208(4):1357-1372. PubMed ID: 29444806
[No Abstract] [Full Text] [Related]
37. CRISPR/Cas9 ribonucleoprotein (RNP) complex enables higher viability of transfected cells in genome editing of acute myeloid cells.
Cheng Q; Xia J; Wang K; Zhang Y; Chen Y; Zhong Q; Wang X; Wu Q
Ann Transl Med; 2022 Aug; 10(16):862. PubMed ID: 36111017
[TBL] [Abstract][Full Text] [Related]
38. CRISPR-cas9 genome editing delivery systems for targeted cancer therapy.
Ghaemi A; Bagheri E; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
Life Sci; 2021 Feb; 267():118969. PubMed ID: 33385410
[TBL] [Abstract][Full Text] [Related]
39. Targeted mutagenesis in wheat microspores using CRISPR/Cas9.
Bhowmik P; Ellison E; Polley B; Bollina V; Kulkarni M; Ghanbarnia K; Song H; Gao C; Voytas DF; Kagale S
Sci Rep; 2018 Apr; 8(1):6502. PubMed ID: 29695804
[TBL] [Abstract][Full Text] [Related]
40. Clustered Regularly Interspaced Short Palindromic Repeats and Clustered Regularly Interspaced Short Palindromic Repeats-Associated Protein 9 System: Factors Affecting Precision Gene Editing Efficiency and Optimization Strategies.
Li J; Tang C; Liang G; Tian H; Lai G; Wu Y; Liu S; Zhang W; Liu S; Shao H
Hum Gene Ther; 2023 Dec; 34(23-24):1190-1203. PubMed ID: 37642232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
